JPMorgan Chase & Co’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.51K | Sell |
|
|||||
|
2025
Q1 | $28.7K | Buy |
|
|||||
|
2024
Q4 | $21.9K | Buy |
|
|||||
|
2024
Q3 | $67.9K | Buy |
|
|||||
|
2024
Q2 | $91.3K | Buy |
|
|||||
|
2024
Q1 | $6.57K | Sell |
|
|||||
|
2023
Q4 | $6.88K | Sell |
|
|||||
|
2023
Q3 | $24.2K | Sell |
|
|||||
|
2023
Q2 | $1.35M | Sell |
|
|||||
|
2023
Q1 | $2.68M | Sell |
|
|||||
|
2022
Q4 | $5.11M | Sell |
|
|||||
|
2022
Q3 | $5.69M | Sell |
|
|||||
|
2022
Q2 | $5.94M | Sell |
|
|||||
|
2022
Q1 | $12.4M | Sell |
|
|||||
|
2021
Q4 | $19M | Sell |
|
|||||
|
2021
Q3 | $29.4M | Buy |
|
|||||
|
2021
Q2 | $31.9M | Buy |
|
|||||
|
2021
Q1 | $14.7M | Buy |
|
|||||
|
2020
Q4 | $9.71M | Buy |
|
|||||
|
2020
Q3 | $7.11M | Buy |
|
|||||
|
2020
Q2 | $16.1M | Buy |
|
|||||
|
2020
Q1 | $3.31M | Buy |
|
|||||
|
2019
Q4 | $561K | Sell |
|
|||||
|
2019
Q3 | $925K | Buy |
|
|||||
|
2019
Q2 | $1.24M | Buy |
|
|||||
|
2019
Q1 | $110K | Buy |
|
|||||
|
2018
Q4 | $114K | Buy |
|
|||||
|
2018
Q3 | $143K | Buy |
|
|||||
|
2018
Q2 | $66K | Sell |
|
|||||
|
2018
Q1 | $98K | Sell |
|
|||||
|
2017
Q4 | $89K | Buy |
|
|||||
|
2017
Q3 | $21K | Buy |
|
|||||
|
2017
Q2 | $23K | Buy |
|
|||||
|
2017
Q1 | $16K | Buy |
|
|||||
|
2016
Q4 | $18K | Buy |
|
|||||
|
2016
Q3 | $6K | Sell |
|
|||||
|
2016
Q2 | $66K | Sell |
|
|||||
|
2016
Q1 | $118K | Buy |
|
|||||
|
2015
Q4 | $78K | Sell |
|
|||||
|
2015
Q3 | $209K | Buy |
|
|||||
|
2015
Q2 | $289K | Buy |
|
|||||
|
2015
Q1 | $134K | Buy |
|
|||||
|
2014
Q4 | $127K | Hold |
|
|||||
|
2014
Q3 | $136K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $121K | Buy |
|